GLP1R and atherosclerosis: Among GLP-1 receptor agonist users, the mean age (± SD) was 62.9 ± 12.2 years, 58.8% were men, 67.1% were obese (BMI ≥30 kg/m2) and 23.0% had a history of ASCVD.